Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
708 | 12194 | 28.0 | 61% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
24 | 112627 | HYPERTENSION//JOURNAL OF HYPERTENSION//HEART FAILURE |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CALCIUM ANTAGONISTS | Author keyword | 110 | 30% | 3% | 314 |
2 | AMLODIPINE | Author keyword | 108 | 28% | 3% | 324 |
3 | ISRADIPINE | Author keyword | 104 | 48% | 1% | 160 |
4 | CILNIDIPINE | Author keyword | 93 | 74% | 1% | 70 |
5 | LACIDIPINE | Author keyword | 84 | 56% | 1% | 104 |
6 | LERCANIDIPINE | Author keyword | 81 | 62% | 1% | 84 |
7 | NIFEDIPINE | Author keyword | 73 | 18% | 3% | 379 |
8 | DILTIAZEM | Author keyword | 62 | 23% | 2% | 241 |
9 | BENIDIPINE | Author keyword | 59 | 62% | 1% | 61 |
10 | HYDROCHLOROTHIAZIDE | Author keyword | 58 | 24% | 2% | 217 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CALCIUM ANTAGONISTS | 110 | 30% | 3% | 314 | Search CALCIUM+ANTAGONISTS | Search CALCIUM+ANTAGONISTS |
2 | AMLODIPINE | 108 | 28% | 3% | 324 | Search AMLODIPINE | Search AMLODIPINE |
3 | ISRADIPINE | 104 | 48% | 1% | 160 | Search ISRADIPINE | Search ISRADIPINE |
4 | CILNIDIPINE | 93 | 74% | 1% | 70 | Search CILNIDIPINE | Search CILNIDIPINE |
5 | LACIDIPINE | 84 | 56% | 1% | 104 | Search LACIDIPINE | Search LACIDIPINE |
6 | LERCANIDIPINE | 81 | 62% | 1% | 84 | Search LERCANIDIPINE | Search LERCANIDIPINE |
7 | NIFEDIPINE | 73 | 18% | 3% | 379 | Search NIFEDIPINE | Search NIFEDIPINE |
8 | DILTIAZEM | 62 | 23% | 2% | 241 | Search DILTIAZEM | Search DILTIAZEM |
9 | BENIDIPINE | 59 | 62% | 1% | 61 | Search BENIDIPINE | Search BENIDIPINE |
10 | HYDROCHLOROTHIAZIDE | 58 | 24% | 2% | 217 | Search HYDROCHLOROTHIAZIDE | Search HYDROCHLOROTHIAZIDE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NIFEDIPINE | 188 | 21% | 6% | 780 |
2 | ACTING CALCIUM ANTAGONIST | 98 | 94% | 0% | 34 |
3 | URGENCIES | 86 | 90% | 0% | 37 |
4 | NITRENDIPINE | 69 | 38% | 1% | 145 |
5 | CALCIUM ANTAGONISTS | 66 | 20% | 2% | 289 |
6 | BENAZEPRIL HYDROCHLORIDE | 65 | 84% | 0% | 36 |
7 | COZAARR TABLETS | 65 | 95% | 0% | 21 |
8 | AMLODIPINE | 64 | 24% | 2% | 238 |
9 | NORVERAPAMIL | 61 | 71% | 0% | 49 |
10 | BESYLATE | 55 | 77% | 0% | 37 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REVUE DE MEDECINE | 3 | 13% | 0% | 19 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Analysis of Sartans: A Review | 2014 | 5 | 134 | 84% |
RECEPTOR-SITES FOR CA2+ CHANNEL ANTAGONISTS | 1992 | 310 | 33 | 48% |
AMLODIPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN CARDIOVASCULAR-DISEASE | 1991 | 143 | 83 | 89% |
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina | 1999 | 141 | 97 | 67% |
CLINICAL PHARMACOKINETICS OF AMLODIPINE | 1992 | 117 | 20 | 95% |
AMLODIPINE - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN CARDIOVASCULAR-DISEASE | 1995 | 98 | 123 | 73% |
CALCIUM ANTAGONISM AND CALCIUM ENTRY BLOCKADE | 1986 | 1089 | 748 | 35% |
CLASSIFICATION OF CALCIUM CHANNELS AND THE SITES OF ACTION OF DRUGS MODIFYING CHANNEL FUNCTION | 1992 | 251 | 108 | 41% |
Clevidipine: A Review of Its Use for Managing Blood Pressure in Perioperative and Intensive Care Settings | 2014 | 3 | 41 | 73% |
CALCIUM CHANNELS - MOLECULAR PHARMACOLOGY, STRUCTURE AND REGULATION | 1988 | 370 | 272 | 44% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTIOXIDANT PHARMACOL | 4 | 75% | 0.0% | 3 |
2 | CLIN PHARMACOL GERIATR MED | 4 | 75% | 0.0% | 3 |
3 | IL DRUG DISCOVERY NEW CHEM ENTITIES DEV | 4 | 75% | 0.0% | 3 |
4 | ANALYT PHARMACOKINET | 3 | 60% | 0.0% | 3 |
5 | BIOANALYT DRUG DEV | 3 | 17% | 0.1% | 14 |
6 | BASIC MED SCI BIOPHYS | 2 | 67% | 0.0% | 2 |
7 | HVIDOVRE HOSP MED CARDIOL | 2 | 67% | 0.0% | 2 |
8 | REGULATORY ANALYT SCI | 2 | 67% | 0.0% | 2 |
9 | MED BIOCHEM CARDIOVASC BIOL | 2 | 30% | 0.0% | 6 |
10 | DRUG DEPENDENCE UNIT | 2 | 21% | 0.1% | 7 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000019202 | CONOTOXIN//MIBEFRADIL//CONOTOXINS |
2 | 0.0000015675 | VARIANT ANGINA//CORONARY SPASM//SILENT ISCHEMIA |
3 | 0.0000013808 | CARVEDILOL//NEBIVOLOL//BETA BLOCKERS |
4 | 0.0000013506 | HEREDITARY ANGIOEDEMA//C1 INHIBITOR//ANGIOEDEMA |
5 | 0.0000011575 | NITRATE TOLERANCE//NITROGLYCERIN//ORGANIC NITRATES |
6 | 0.0000010323 | CICLETANINE//TIROPRAMIDE//MUSANGA CECROPIOIDES |
7 | 0.0000008357 | MEDICATION ADHERENCE//JOURNAL OF HUMAN HYPERTENSION//BLOOD PRESSURE CONTROL |
8 | 0.0000008291 | OTILONIUM//OTILONIUM BROMIDE//PREGNENOLONE SUBSTRATE |
9 | 0.0000008199 | LEFT VENTRICULAR HYPERTROPHY//POST EXERCISE HYPOTENSION//LEFT VENTRICULAR MASS |
10 | 0.0000007141 | CARDIOPLEGIA//JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY//CARIPORIDE |